WATSON 787 25mg
Pill imprint WATSON 787 25mg has been identified as Chlordiazepoxide hydrochloride 25 mg.
Chlordiazepoxide is used in the treatment of alcohol withdrawal; anxiety; light sedation; tardive dyskinesia; panic disorder (and more), and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy.
Chlordiazepoxide 25 mg has a low potential for abuse. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Chlordiazepoxide hydrochloride Images
- Imprint:
-
WATSON 787
25mg - Strength:
- 25 mg
- Color:
- Green & White
- Size:
- 4.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
microcrystalline cellulose
hydrogenated vegetable oil
gelatin
methylparaben
propylparaben
silicon dioxide
sodium lauryl sulfate
titanium dioxide
- Drug Class:
- Benzodiazepines
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0787
Advertisement
More Chlordiazepoxide Hydrochloride resources
- Chlordiazepoxide (Wolters Kluwer)
- Chlordiazepoxide Injection (Wolters Kluwer)
- chlordiazepoxide (Cerner Multum)
- Libritabs (Micromedex) - Includes Dosage Information
- chlordiazepoxide (Micromedex) - Includes Dosage Information
- chlordiazepoxide hydrochloride (Micromedex) - Includes Dosage Information
- Chlordiazepoxide (AHFS DI)
- Chlordiazepoxide Hydrochloride (AHFS DI)
- Chlordiazepoxide (FDA)
- Chlordiazepoxide Capsules (FDA)
- Chlordiazepoxide (Wolters Kluwer)
Search Again
